Derek R Johnson, Joshua D Palmer, Michelle M Kim, William G Breen
Journal: PET clinics 2025;20(2):195-204
PMID: 39915188
The investigation and application of PET modalities for the evaluation and treatment of patients with central nervous system (CNS) tumors continues to evolve, with anticipated increased uptake in the United States for both benign and malignant CNS tumors in the decade to come.
Copyright © 2025 Elsevier Inc. All rights reserved.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.